SowaStaszczak Nasz zespół Medicina
Anna SowaJadczyk Kondrat
Anna Sowa-Staszczak 1 , Agnieszka Stefanska, Pawel Chrapczynski, Malgorzata Trofimiuk-Müldner, Miroslaw Szura, Alicja Hubalewska-Dydejczyk Affiliation 1 Department of Endocrinology, University Hospital, Krakow, Poland.
Słowo za słowo Anna SowaStaszczak 08.11.2019 YouTube
Anna Sowa-Staszczak. Department of Endocrinology, University Hospital in Krakow, Krakow, Poland. Search for more papers by this author. Agnieszka Stefańska, Agnieszka Stefańska. Department of Endocrinology, University Hospital in Krakow, Krakow, Poland.
Table I from Gastroduodenal neuroendocrine neoplasms including
Anna Sowa-Staszczak Wioletta Lenda-Tracz 23677758 10.5603/NMR.2013.0003 Somatostatin receptor scintigraphy (SRS) is a useful tool in the assessment of GEP-NET (gastroenteropancreatic neuroendocrine tumor) patients. The choice of appropriate settings of image reconstruction parameters is crucial in interpretation of these images.
Figure 1 from GlucagonLike Peptide1 Receptor Imaging with [Lys 40
Articles by author - Anna Sowa-Staszczak. Coexistence of neurofibromatosis type 1 with multiple malignant neoplasia. Przybylik-Mazurek E,. Sowa-Staszczak A, Brzozowska-Czarnek A, Hubalewska-Dydejczyk A. Coexistence of neurofibromatosis type 1 with multiple malignant neoplasia. Neuro Endocrinol Lett. 2018 Sep; 39(3): 149-155
Table 1 from 99mTc Labeled GlucagonLike Peptide1Analogue (99mTcGLP1
Anna Sowa-Staszczak 1, Alicja Hubalewska-Dydejczyk 1, Jolanta Kunikowska 2, Leszek Królicki 2, Renata Mikolajczak 3, Dariusz Pawlak 3, Aleksandra Gilis-Januszewska 1, Malgorzata Trofimiuk 1 & Agnieszka Stefanska 1
„Honoris Gratia” dla prof. Anny SowyStaszczak Szpital Uniwersytecki
Diagnostic imaging of NEN. Diagnostic imaging of neuroendocrine tumours plays a fundamental role in diagnosis, staging, selection of treatment method, assessment for radioisotope therapy and monitoring response to treatment (1,2).Diagnostic imaging methods make it possible not only to detect tumours, but also to perform therapeutic procedures based on the result.
Prof. dr hab. n. med. Anna SowaStaszczak odebrała nominację...
PMCID: PMC8670552 PMID: 34917031 Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma Marta Opalińska, 1 Anna Sowa-Staszczak, 2 , * Helena Olearska, 2 Magdalena Ulatowska-Bialas, 3 Aleksandra Gilis-Januszewska, 2 and Alicja Hubalewska-Dydejczyk 2
(PDF) Difficulties in the diagnosis and treatment of malignant
Anna Sowa-Staszczak 1 , Dorota Pach, Agnieszka Stefańska, Monika Tomaszuk, Wioletta Lenda-Tracz, Renata Mikołajczak, Dariusz Pawlak, Robert Chrzan, Aleksandra Gilis-Januszewska, Elwira Przybylik-Mazurek, Alicja Hubalewska-Dydejczyk
Prof. dr hab. n. med. Anna SowaStaszczak Umów wizytę online
Background and Objectives: Long-acting somatostatin analogues (SSA) (octreotide LAR and lanreotide Autogel) are recommended as first line treatment of locally advanced or metastatic well-differentiated neuroendocrine tumors (NETs) with a good expression of somatostatin receptor (SSTR).
(PDF) Radioimmunothetapy in follicular lymphomas, a retrospective
Anna Sowa-Staszczak's research works | Jagiellonian University, Kraków (UJ) and other places Anna Sowa-Staszczak's research while affiliated with Jagiellonian University and other places.
Anna Sowa Finance Analyst in Finance Team Regional Controlling, UBS
Contributors: Helena Olearska; Anna Sowa-Staszczak; Karolina Morawiec-Sławek; Anna Kurzyńska; Magdalena Kolasa; Edyta Tkacz; Małgorzata Szumińska; Alicja Hubalewska-Dydejczyk; Marta Opalińska Show more detail. Source: check_circle. Crossref Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related.
SowaStaszczak Nasz zespół Medicina
Marta Opalińska, 1 Karolina Morawiec-Sławek, 2 Adrian Kania-Kuc, 1 Ibraheem Al Maraih, 1 Anna Sowa-Staszczak, 2 , * and Alicja Hubalewska-Dydejczyk 2 Marta Opalińska 1 Nuclear Medicine Unit, Endocrinology Department, University Hospital in Krakow, Krakow, Poland
(PDF) Saddle pulmonary embolism as a fatal complication of the Cushing
Agnieszka Stefańska 1, Anna Sowa-Staszczak 1, Alicja Hubalewska-Dydejczyk 1 & Renata Mikołajczak 2. Peptide receptor radionuclide therapy as neoadjuvant treatment. 0 Views Author affiliations. 1 Hospital University Medical College.
Kraków 10 listopada koncert popularyzujący wiedzę nt. nowotworów
Anna Staszczak-Sowa practices in Krakow, Poland. Staszczak-Sowa and is highly rated in 10 conditions, according to our data. Her top areas of expertise are Insulinoma, Neuroendocrine Tumor, Ectopic Cushing's syndrome, and Medullary Thyroid Carcinoma. Her clinical rese.
Uczyła lekarkę śpiewu i stworzyły zgrany duet. Razem są w stanie
Marta Opalińska , Anna Sowa-Staszczak 2 , Helena Olearska 3 34917031 PMCID: PMC8670552 10.3389/fendo.2021.770266 Neuroendocrine neoplasms are a heterogeneous group of cancers that develop from enterochromaffin cells of the diffuse endocrine system, with an increase in incidents over the last years.
(PDF) The Usefulness of [18F]FFluorodeoxyglucose and [18F]FSodium
Anna Sowa-Staszczak 1 , Małgorzata Trofimiuk-Müldner 1 , Agnieszka Stefańska 1 , Monika Tomaszuk 1 , Monika Buziak-Bereza 1 , Aleksandra Gilis-Januszewska 1 , Agata Jabrocka-Hybel 1 , Bogusław Głowa 2 , Maciej Małecki 3 , Tomasz Bednarczuk 4 , Grzegorz Kamiński 5 , Aldona Kowalska 6 , Renata Mikołajczak 7 , Barbara Janota 7 , Alicja.
